Year To Quarter End Statement Of Income

Kidswell Bio Corporation - Filing #7334127

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Year to quarter end statement of income
Statement of income
Net sales
2,776,241,000 JPY
1,569,232,000 JPY
Cost of sales
1,250,553,000 JPY
550,357,000 JPY
Gross profit (loss)
1,525,688,000 JPY
1,018,875,000 JPY
Selling, general and administrative expenses
2,076,617,000 JPY
1,670,014,000 JPY
Selling, general and administrative expenses
Depreciation
928,000 JPY
2,254,000 JPY
Operating profit (loss)
-550,929,000 JPY
-651,139,000 JPY
Non-operating income
Interest income
12,000 JPY
936,000 JPY
Non-operating income
3,980,000 JPY
43,337,000 JPY
Non-operating expenses
Interest expenses
32,760,000 JPY
15,460,000 JPY
Non-operating expenses
77,820,000 JPY
360,733,000 JPY
Ordinary profit (loss)
-624,769,000 JPY
-968,535,000 JPY
Extraordinary income
Extraordinary income
JPY
418,881,000 JPY
Extraordinary losses
Extraordinary losses
31,454,000 JPY
JPY
Profit (loss) before income taxes
-656,224,000 JPY
-549,653,000 JPY
Income taxes - current
1,210,000 JPY
1,210,000 JPY
Income taxes
1,210,000 JPY
1,210,000 JPY
Profit (loss)
-657,434,000 JPY
-657,434,000 JPY
-657,434,000 JPY
-657,434,000 JPY
-550,863,000 JPY
-550,863,000 JPY
-550,863,000 JPY
-550,863,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.